#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary cancer metastatic Hypergammaglobulinaemia benign monoclonal Pancreatic neuroendocrine tumour Undifferentiated sarcoma Basal cell naevus syndrome Porphyria non-acute Aspergillus infection Measles Deafness Astrocytoma malignant Hereditary spastic paraplegia Rheumatoid arthritis Dent's disease Angiosarcoma metastatic Bronchiolitis More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Trials in Disease Congenital nephrogenic diabetes insipidus – Treatment Activated PI3 kinase delta syndrome Pituitary-dependent Cushing’s syndrome Mucopolysaccharidosis I – Treatment Leiomyosarcoma metastatic – Life with Disease Glomerulonephritis membranous – Basic Information Myelodysplastic syndrome – Basic Information Nodal marginal zone B-cell lymphoma Chordoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propofol T89 Azetukalner Bgb-A445 Ublituximab GSKVX000000034797 Dronedarone Thiamazole Xxb750 Cart45Ra-Nkg2D Cells REGN7999 Ro7269162 Ads-015 Csm-Gw Apg777 Bi 1291583 Trimethoprim Tilmanocept Triheptanoin Atomoxetine Hydrochloride More therapies…

    Learn about Your Condition

    Fontan procedure Large cell lung cancer stage 0 Pulmonary hypertension Colonoscopy Epicondylitis Breast cancer male Malignant melanoma stage IV Cytomegalovirus infection Cholangiocarcinoma Lymphoedema Large cell lung cancer Postoperative delirium Post procedural swelling Breast cancer stage I Glioblastoma multiforme More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Polycythaemia vera

  • Study of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    • Essential thrombocythaemia
    • Myelofibrosis
    Investigated Drugs:
    • Gandotinib
    Austria Germany Spain

  • Study of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Polycythaemia vera
    Investigated Drugs:
    • Ruxolitinib
    Germany

  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease in intestine
    • Acute graft versus host disease in liver
    • Acute graft versus host disease in skin
    Investigated Drugs:
    • Panobinostat
    • Siremadlin
    • Ruxolitinib
    Germany Italy Poland Sweden

  • Study on the Effects of Rusfertide (PTG-300) for Patients with Polycythemia Vera

    Not recruiting

    3 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Rusfertide
    Austria Belgium Czechia France Germany Hungary +5

  • Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Sapablursen
    Poland

  • Study on Hydroxycarbamide Resistance in Patients with Polycythemia Vera Identified by AI Predictors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Hydroxycarbamide
    Germany
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!